Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Cephalon's narcolepsy treatment available in Austria

May 27, 1999

CoCensys and Parke-Davis collaboration yields development compound

May 27, 1999

Fluvoxamine maleate launched in Japan for social anxiety disorder

May 26, 1999

Yoshitomi discloses new antipsychotics in recent patent literature

May 26, 1999

Ortho-McNeil describes new dipyridoimidazole series of GABA-A receptor ligands

May 26, 1999

NeuroSearch-Meiji Seika team discovers positive modulators of GABA-A receptor complex

May 26, 1999

Cortex receives SBIR grant for new stroke therapy

May 25, 1999

Tetrahydrofurans as 5-HT2 receptor antagonists: synthesis and preliminary pharmacological evaluation

May 25, 1999

Risperidone may reduce risk of relapse in schizophrenia

May 24, 1999

Research at Kyorin leads to AMPA receptor antagonists with nanomolar affinity

May 21, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...